82 results found.

Metastatic Colorectal Cancer, Metastatic Gastric Cancer, Metastat Clinical Trial using CD8+ young TIL; Aldesleukin; Cyclophosphamide; Fludarabine

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 66 years.
- A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Digestive Tract Cancers.
CD8+ young TIL; Aldesleukin; Cyclophosphamide; Fludarabine

Gastric Cancer Clinical Trial using GDC-0068; Placebo; mFOLFOX6

Genentech - Recruiting 18 years or older.
- A Randomized, Phase II, Placebo Controlled Study of GDC-0068, an Inhibitor to Akt, in Combination With Fluoropyrimidine Plus Oxaliplatin in Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma.
GDC-0068; Placebo; mFOLFOX6

Metastatic Advanced Gastric Cancer Clinical Trial using Docetaxel 60 mg/m2, epirubicin 60 mg/m2, q3wks

Yonsei University - Recruiting 20 years or older.
- .
Docetaxel 60 mg/m2, epirubicin 60 mg/m2, q3wks

Gastric Cancer Clinical Trial using Olaparib; Paclitaxel; Placebo

AstraZeneca - Recruiting 18 years or older.
- A Randomized, Double-blinded, Placebo Controlled, Multicentre Phase III Study to Assess the Efficacy and Safety of Olaparib (AZD2281) in Combination With Paclitaxel, Compared to Placebo in Combination With Paclitaxel, in Asian Patients With Advanced Gastric Cancer (Including the Gastro-oesophageal Junction) Who Have Progressed Following First Line Therapy.
Olaparib; Paclitaxel; Placebo

Esophageal Cancer, or Gastric Cancer Clinical Trial using Afatinib (BIBW 2992)

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Afatinib (BIBW 2992) in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer.
Afatinib (BIBW 2992)

Helicobacter Pylori Infections, Atrophic Gastritis, or Gastric Ca Clinical Trial using Triple therapy

International Agency for Research on Cancer - Recruiting 40 years to 64 years.
- Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality.
Triple therapy

Esophageal Cancer, Bile Duct Neoplasms, Gastric Cancer, Liver Can Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites..

Gastric Cancer Clinical Trial using pertuzumab [Perjeta]; placebo; trastuzumab [Herceptin]; cisplatin; capecitabine; 5-fluorouracil

Hoffmann-La Roche - Recruiting 18 years or older.
- A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTICENTER PHASE III STUDY EVALUATING THE EFFICACY AND SAFETY OF PERTUZUMAB IN COMBINATION WITH TRASTUZUMAB AND CHEMOTHERAPY IN PATIENTS WITH HER2-POSITIVE METASTATIC GASTROESOPHAGEAL JUNCTION OR GASTRIC CANCER.
pertuzumab [Perjeta]; placebo; trastuzumab [Herceptin]; cisplatin; capecitabine; 5-fluorouracil

Gastric Cancer Clinical Trial using trastuzumab emtansine; taxane

Hoffmann-La Roche - Recruiting 18 years or older.
- A Randomized, Multicenter, Adaptive Phase II/III Study To Evaluate The Efficacy And Safety Of Trastuzumab Emtansine (T-DM1) Versus Taxane (Docetaxel Or Paclitaxel) In Patients With Previously Treated Locally Advanced Or Metastatic Her2-Positive Gastric Cancer, Including Adenocarcinoma Of The Gastroesophageal Junction.
trastuzumab emtansine; taxane

Gastric Cancer Clinical Trial using Onartuzumab; Placebo; mFOLFOX6

Hoffmann-La Roche - Recruiting 18 years or older.
- A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating The Efficacy And Safety Of Onartuzumab (MetMAb) In Combination With 5-Fluorouracil, Folinic Acid, And Oxaliplatin (mFOLFOX6) In Patients With Metastatic Her2-Negative, Met-Positive Gastroesophageal Cancer (MetGastric).
Onartuzumab; Placebo; mFOLFOX6

Gastric Cancer Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- A NON-INTERVENTIONAL, REGISTRY STUDY FOR CHINESE GASTRIC CANCER PATIENTS WITH HER2 STATUS: CLINICAL AND PATHOLOGICAL CHARACTERISTICS, TREATMENT PATTERNS AND CLINICAL OUTCOMES.

Stomach Neoplasms; Esophageal Neoplasms; Metastatic Gastric Cance Clinical Trial using AUY922; BYL719

Novartis - Recruiting 18 years or older.
- A Phase IB, Multicenter, Open-label Dose Escalation Study of the PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer Carrying a Molecular Alteration of PIK3CA or an Amplification of HER2.
AUY922; BYL719

Advanced HER2-positive Breast Cancer or Gastric Cancer Clinical Trial using LJM716; Trastuzumab

Novartis - Recruiting 18 years or older.
- A Multicenter, Open-label, Dose Escalation, Phase I Study of LJM716 Administered Intravenously in Combination With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast Cancer or Gastric Cancer.
LJM716; Trastuzumab

Advanced Gastric Cancer Clinical Trial using taxel plus raltitrexed; taxol

Fudan University - Recruiting 18 years to 75 years.
- Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer Stage II Randomized Controlled Clinical Studies.
taxel plus raltitrexed; taxol

Colorectal Neoplasms, Gastric Neoplasms, Cholangiocarcinoma, Bile Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- Tumor, Normal Tissue and Specimens From Patients Undergoing Evaluation or Surgical Resection of Solid Tumors.

Gastric Cancer Clinical Trial using trastuzumab [Herceptin]; capecitabine; cisplatin

Hoffmann-La Roche - Recruiting 18 years or older.
- .
trastuzumab [Herceptin]; capecitabine; cisplatin

Gastric Cancer Clinical Trial using trastuzumab [Herceptin]; Oxaliplatin; capecitabine; Radiation

Hoffmann-La Roche - Recruiting 18 years to 75 years.
- Safety and Tolerability of Oxaliplatin-Capecitabine-Trastuzumab Combination and Chemoradiotherapy in Adjuvant Setting in Operated HER2+ Patients With Gastric or Gastroesophageal Junction Adenocarcinoma: A Phase II Study (TOXAG Study).
trastuzumab [Herceptin]; Oxaliplatin; capecitabine; Radiation

Gastric Cancer With Metabolic Syndrome or Metabolic Disease Clinical Trial using subtotal gastrectomy with gastroduodenostomy; subtotal gastrectomy with Roux-en-Y gastrojejunostomy,; total gastrectomy with Rou-en-Y esophagojejunostomy

Yonsei University - Recruiting 20 years to 80 years.
- .
subtotal gastrectomy with gastroduodenostomy; subtotal gastrectomy with Roux-en-Y gastrojejunostomy,; total gastrectomy with Rou-en-Y esophagojejunostomy

Breast Cancer, Colorectal Cancer, Gastric Cancer, Malignant Melan Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- OCCURRENCE RATE OF COLON CANCER, BREAST CANCER, GASTRIC CANCER AND MALIGNANT MELANOMA IN TURKEY & DIAGNOSIS AND TREATMENT CHARACTERISTICS.

Early Gastric Cancer or Gastric Adenoma Clinical Trial using Arm1: Without Simvastar; Arm2: With simvastar

Yonsei University - Recruiting 20 years to 70 years.
- .
Arm1: Without Simvastar; Arm2: With simvastar

Gastric Cancer,Rare Cancer Clinical Trial

Samsung Medical Center - Recruiting 20 years or older.
- Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer.

Breast Cancer, or Gastric Cancer Clinical Trial using Trastuzumab + NK cells

National University Hospital, Singapore - Recruiting 21 years or older.
- Phase I/II Study of Expanded, Activated Autologous Natural Killer Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer.
Trastuzumab + NK cells

Stage IV Gastric Cancer Clinical Trial using Paclitaxel

Daehwa Pharmaceutical Co., Ltd. - Recruiting 20 years or older.
- A Randomized, Open, Multicenter Phase 3 Study for Efficacy and Safety Assessment of DHP107 (Oral Paclitaxel) vs. Taxolr in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy With Fluoropyrimidine +/- Platinum.
Paclitaxel

Gastric Cancer Clinical Trial using Rilotumumab; Placebo

Amgen - Recruiting 18 years or older.
- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Rilotumumab (AMG102) With Epirubicin, Cisplatin, and Capecitabine (ECX) as First-line Therapy in Advanced MET-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.
Rilotumumab; Placebo

Gastric Cancer, or Gastroesophageal Junction Cancer Clinical Trial using Cisplatin-5FU-Afatinib

Hellenic Cooperative Oncology Group - Recruiting 18 years or older.
- A Phase II, Single-arm Clinical Trial of Administration of Cisplatin and 5- Fluorouracil With Afatinib as First-line Therapy in Patients With Inoperable Gastric or Gastroesophageal Junction Cancer.
Cisplatin-5FU-Afatinib

Gastric Cancer Clinical Trial using LATG

Soonchunhyang University Hospital - Recruiting 20 years to 80 years.
- Prospective Multi-center Study of Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03).
LATG

Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individual With Cancer.

Gastric Cancer, or Pancreatic Cancer Clinical Trial using questionnaire, Blood specimens

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Gastroenteropancreatic and Unknown Primary Neuroendocrine Registry A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors.
questionnaire, Blood specimens

Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of t Clinical Trial using Ipilimumab; Best Supportive care (BSC)

Bristol-Myers Squibb - Recruiting 18 years or older.
- A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer.
Ipilimumab; Best Supportive care (BSC)

Gastric Cancer Clinical Trial

Hospital Miguel Servet - Recruiting 18 years or older.
- Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients: A Prospective Observational Study ('EXO-PPP Study').

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesop Clinical Trial using oxaliplatin; leucovorin calcium; fluorouracil; therapeutic conventional surgery; radiation therapy; carboplatin; paclitaxel

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of Modified FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Response Based Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Adenocarcinoma of the Esophagus, Gastro-esophageal Junction, and Gastric Cardia.
oxaliplatin; leucovorin calcium; fluorouracil; therapeutic conventional surgery; radiation therapy; carboplatin; paclitaxel

Esophageal Cancer, or Gastric Cancer Clinical Trial using Regorafenib; 5-Fluorouracil; Leucovorin; Oxaliplatin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer.
Regorafenib; 5-Fluorouracil; Leucovorin; Oxaliplatin

Patients Need Upper Gastrointestinal Endoscopy, Peptic Ulcer, Gas Clinical Trial

RenJi Hospital - Recruiting 18 years or older.
- Adverse Events During Upper Gastrointestinal Endoscopy With and Without Sedation: a Multiple Center Report From Shanghai.

Gastric Cancer Clinical Trial using Ramucirumab

Eli Lilly and Company - Recruiting 20 years or older.
- A Phase 2 Study of Ramucirumab in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First Line Platinum- or Fluoropyrimidine-Containing Combination Therapy in Japanese Patients.
Ramucirumab

Gastric Cancer Clinical Trial using RAD001

Chinese University of Hong Kong - Recruiting 18 years or older.
- Phase I/II Study of Paclitaxel / Carboplatin / RAD001 as First Line Therapy for Advanced Adenocarcinoma of the Stomach.
RAD001

Advanced Gastric Cancer, or Esophagogastric Junction Cancer Clinical Trial using Paclitaxel; RAD001

Krankenhaus Nordwest - Recruiting 18 years or older.
- A Randomized, Double-blind, Multi-center Phase III Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma Who Have Progressed After Therapy With a Fluoropyrimidine-containing Regimen.
Paclitaxel; RAD001

Gastric Cancer Clinical Trial using Cabazitaxel

Krankenhaus Nordwest - Recruiting 18 years or older.
- Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach.
Cabazitaxel

Advanced Gastric Cancer Clinical Trial using Docetaxel, Capecitabine, Cisplatin, Bevacizumab

Asan Medical Center - Recruiting 18 years to 70 years.
- A Phase II Study of Neoadjuvant Chemotherapy With Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer.
Docetaxel, Capecitabine, Cisplatin, Bevacizumab

Gastroesophageal Junction Adenocarcinoma, or Gastric Cancer Clinical Trial using Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma.
Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen

Advanced Gastric Cancer Clinical Trial using Cisplatin, TS-1 and oxaliplatin

National University Hospital, Singapore - Recruiting 21 years or older.
- .
Cisplatin, TS-1 and oxaliplatin

Early Gastric Cancer, or Gastric Adenoma Clinical Trial using Intermittent midazolam/propofol injection controlled by endoscopist; Continuous propofol infusion with opioid administration

Yonsei University - Recruiting 20 years to 80 years.
- .
Intermittent midazolam/propofol injection controlled by endoscopist; Continuous propofol infusion with opioid administration

Metastatic or Recurrent Gastric Adenocarcinoma, or Her-2 Positive Clinical Trial using Herceptin+XELOX

Asan Medical Center - Recruiting 20 years or older.
- A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer.
Herceptin+XELOX

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cance Clinical Trial using FOLFOX regimen; docetaxel; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin

Southwest Oncology Group - Recruiting 18 years or older.
- A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer.
FOLFOX regimen; docetaxel; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin

Gastric Cancer Clinical Trial using Dovitinib

Asan Medical Center - Recruiting 18 years or older.
- A Phase II Trial of Dovitinib Monotherapy as Salvage Treatment in Patients With Metastatic or Unresectable Gastric Cancer Harboring FGFR2(Fibroblast Growth Factor Receptor 2) Amplification After Failure of First or Second Line Chemotherapy.
Dovitinib

Breast Cancer, Ovarian Cancer, Colon Cancer, Lung Cancer, Gastric Clinical Trial using Veliparib (ABT-888); Placebo

AbbVie - Recruiting 18 years or older.
- A Randomized, Placebo-Controlled Crossover Study to Evaluate the Effect of Veliparib (ABT-888) on Cardiac Repolarization in Subjects With Relapsed or Refractory Solid Tumors.
Veliparib (ABT-888); Placebo

Gastric Cancer Clinical Trial using LY2875358

Eli Lilly and Company - Recruiting 20 years or older.
- A Non-Randomized, Open-Label, Single-Arm, Phase 2 Study of LY2875358 in Patients With MET Diagnostic Positive, Advanced Gastric Cancer.
LY2875358

Breast Cancer, Gastric Cancer Clinical Trial using trastuzumab emtansine; capecitabine

Hoffmann-La Roche - Recruiting 18 years or older.
- PHASE I FOLLOWED BY PHASE II STUDY OF THE COMBINATION OF TRASTUZUMAB EMTANSINE (T-DM1) AND CAPECITABINE IN HER2-POSITIVE METASTATIC BREAST CANCER AND HER2-POSITIVE LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER PATIENTS.
trastuzumab emtansine; capecitabine

Gastric Cancer Clinical Trial using questionnaires

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Early Onset and Familial Gastric Cancer Registry.
questionnaires

Gastric Cancer, or Peritoneal Carcinomatosis Clinical Trial using Intraperitoneal docetaxel

The University of Hong Kong - Recruiting 18 years or older.
- Feasibility Study of Intraperitoneal Docetaxel Combined With Intravenous Cisplatin and Oral TS-ONE for Gastric Cancer Patients With Peritoneal Carcinomatosis.
Intraperitoneal docetaxel

Gastric Cancer Clinical Trial using TS-1, oxaliplatin

Samsung Medical Center - Recruiting 20 years or older.
- .
TS-1, oxaliplatin

Gastric Cancer Clinical Trial using Laparoscopy-assisted gastrectomy

Seoul National University Bundang Hospital - Recruiting 20 years to 80 years.
- Phase III Prospective Randomized Clinical Trial of Laparoscopy-assisted Proximal Gastrectomy (LAPG) and Laparoscopy-assisted Total Gastrectomy (LATG) for Upper Gastric Cancer. (Multicenter Study).
Laparoscopy-assisted gastrectomy

Helicobacter Pylori, Eradication, Gastric Cancer, or Medical Care Clinical Trial

Showa Inan General Hospital - Recruiting 19 years to 69 years.
- The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town.

Gastric Cancer Clinical Trial using albumin-bounded paclitaxel; S-1

Chinese Academy of Medical Sciences - Recruiting 18 years or older.
- Pase 2 Study of Albumin-bounded Paclitaxel Plus S-1 as First-line Chemotherapy for Locally Advanced or Metastatic Gastric or Gastro-esophageal Adenocarcinoma.
albumin-bounded paclitaxel; S-1

Stomach Cancer, Gastro-Esophageal(GE) Junction Cancer, Gastric (S Clinical Trial using Blood draw; Tissue tumor biopsy

Stanford University - Recruiting 18 years or older.
- Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma.
Blood draw; Tissue tumor biopsy

Solid Tumors Clinical Trial using MSB0010718C

Merck KGaA - Recruiting 20 years or older.
- A Phase I Trial to Investigate the Tolerability, Safety, Pharmacokinetics, Biological and Clinical Activity of MSB0010718C in Japanese Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion Part in Asian Subjects With Gastric Cancer.
MSB0010718C

Gastric Cancer, Intestinal Metaplasia, Atrophic Gastritis, or Inf Clinical Trial using probe-based confocal laser endomicroscopy

Shandong University - Recruiting 18 years to 80 years.
- New Classification of Gastric Pit Patterns and Vessel Architecture Using Probe-based Confocal Laser Endomicroscopy.
probe-based confocal laser endomicroscopy

Esophageal Neoplasm, or Gastric Neoplasm Clinical Trial using Omegaven

University Hospitals, Leicester - Recruiting 18 years or older.
- Phase II Trial of Palliative Epirubicin, Oxaliplatin & Capecitabine (EOX) Chemotherapy Combined With Omega-3 Fish Oil Infusion (Omegaven) in Patients With Oesophagogastric Carcinoma.
Omegaven

Rectal Cancer, Gastric Cancer, Bone Marrow Toxicity, or Adverse E Clinical Trial using Bone Marrow-sparing Intensity-Modulated Radiotherapy

Chinese Academy of Medical Sciences - Recruiting 18 years to 75 years.
- Phase II Clinical Trial: The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy (BMS-IMRT) on Reduction Acute Hematologic Toxicity in Gastric and Rectal Cancer Patients Treated With Concurrent Chemotherapy and IMRT.
Bone Marrow-sparing Intensity-Modulated Radiotherapy

Gastric Cancer Clinical Trial using preemptive dexmedetomidine epidural bolus injection(1.5 mcg/kg); normal saline

Yonsei University - Recruiting 40 years to 70 years.
- .
preemptive dexmedetomidine epidural bolus injection(1.5 mcg/kg); normal saline

Gastric Cancer Clinical Trial using Oxaliplatin; Capecitabine

Harbin Medical University - Recruiting 65 years or older.
- A Randomized Single Center Phase II Study Comparing XELOX With Capecitabine Maintenance or XELOX Treatment in Elderly Metastatic Adenocarcinoma of Stomach.
Oxaliplatin; Capecitabine

Gastric Cancer Clinical Trial using surgery

Zhejiang Cancer Hospital - Recruiting 18 years to 70 years.
- Phase 2 Study of D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer.
surgery

Stomach Neoplasms, Oesophageal Junction Cancer, or Lower Oesophag Clinical Trial using Epirubicin; Cisplatin; Paclitaxel; gastric surgery

Centre Hospitalier Universitaire de Besancon - Recruiting 18 years to 70 years.
- Preoperative Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel (Intensified PET) in Patients With Locally Gastric Cancer : a Phase II Proof-of-concept Study..
Epirubicin; Cisplatin; Paclitaxel; gastric surgery

Early Gastric Cancer Clinical Trial using gastrectomy; Endoscopic submucosal dissection

National Cancer Center, Korea - Recruiting 20 years to 80 years.
- Effect of Gastrectomy and Anastomosis on Chronic Metabolic Disease Such as Diabetes and Hypertension in Early Gastric Cancer Patients.
gastrectomy; Endoscopic submucosal dissection

Esophageal Cancer, or Gastric Cancer Clinical Trial using Oxaliplatin; Folinic Acid; 5-Fluorouracil; Ziv-aflibercept; Ziv-aflibercept Placebo

Dana-Farber Cancer Institute - Recruiting 18 years or older.
- Randomized, Double-Blind, Placebo Controlled Phase II Study of FOLFOX +/- Ziv-Aflibercept in Patients With Advanced Esophageal and Gastric Cancer.
Oxaliplatin; Folinic Acid; 5-Fluorouracil; Ziv-aflibercept; Ziv-aflibercept Placebo

Patients With Gastric Peritoneal Carcinomatosis Clinical Trial using Catumaxomab 100æg; Catumaxomab 140æg

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab. A Randomized Phase II Trial..
Catumaxomab 100æg; Catumaxomab 140æg

Gastric Cancer Patient Clinical Trial using physical activity intervention

Yonsei University - Recruiting 20 years to 70 years.
- .
physical activity intervention

Gastric Carcinoma Stage IV Clinical Trial using XELOX; FOLFOX

Dong-A University Hospital - Recruiting 20 years or older.
- A Phase III Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Capecitabine and Oxaliplatin (XELOX) in Comparison to the Combination Therapy of Fluorouracil/Folinic Acid and Oxaliplatin (FOLFOX) in Patients With AGC.
XELOX; FOLFOX

Gastric Cancer Clinical Trial using S-1; oxaliplatin; cisplatin

Peking University - Recruiting 18 years or older.
- Phase ? Study of S-1 Combined With Oxaliplatin (SOX)Verse S-1 Combined With Cisplatin(SP) in Adjuvant Chemotherapy After D2 Surgery.
S-1; oxaliplatin; cisplatin

Gastric Adenocarcinoma Clinical Trial using Oxaliplatin+S-1; Adjuvant Oxaliplatin/S-1(SOX)

Chinese PLA General Hospital - Recruiting 20 years to 75 years.
- Phase III, Randomized, Multicenter, Controlled Evaluation of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients.
Oxaliplatin+S-1; Adjuvant Oxaliplatin/S-1(SOX)

Gastric Cancer, Stomach Cancer, or Gastrectomy Clinical Trial using Roux-en-Y or Billroth II

National Healthcare Group, Singapore - Recruiting 21 years to 80 years.
- A Prospective Randomised Study Comparing Billroth II With Roux-en-Y Reconstruction After Radical Distal Subtotal Gastrectomy for Gastric Cancer.
Roux-en-Y or Billroth II

Gastrointestinal Neoplasm, or Gastric Adenocarcinoma Clinical Trial using Irinotecan-Capecitabine-Oxaliplatin

AHS Cancer Control Alberta - Recruiting 18 years or older.
- A Multicentre, Open-label Phase II Study of Irinotecan, Capecitabine(Xeloda), and Oxaliplatin (IXO) as First Line Treatment in Patients With Metastatic Gastric or Gastroesophageal (GEJ) Adenocarcinoma..
Irinotecan-Capecitabine-Oxaliplatin

Oesophageal Cancer Clinical Trial using gastric tube

Peking University - Recruiting 30 years to 75 years.
- The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis Esophagectomy: A Randomized Control Trial and Physiological Study.
gastric tube

Stomach Cancer, Gastrectomy, or Ultrasonic Coagulating Shears Clinical Trial using Ultrasonic Coagulating Shears

Samsung Medical Center - Recruiting 20 years to 75 years.
- The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery.
Ultrasonic Coagulating Shears

Gastric Cancer Clinical Trial using laparoscopy-assisted distal gastrectomy; open distal gastrectomy

National Cancer Center, Korea - Recruiting 20 years to 80 years.
- Multi-institutional Prospective Randomized Trial on the Assessment of Laparoscopic Surgery for Gastric Cancer.
laparoscopy-assisted distal gastrectomy; open distal gastrectomy

Gastric Neoplasm Clinical Trial using Gastrectomy with more than D2 dissection; Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy

Japan Clinical Oncology Group - Recruiting 20 years to 75 years.
- Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501).
Gastrectomy with more than D2 dissection; Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy

Advanced Gastric Cancer Clinical Trial using endostar, cisplatin, capecitabine; capecitabine; cisplatin

Peking University - Recruiting 18 years to 75 years.
- A Phase II Study of Endostar (Recombinant Human Endostatin r) With Cisplatin and Capecitabine (Xeloda) as 1st Line Treatment in the Advanced Gastric Cancer.
endostar, cisplatin, capecitabine; capecitabine; cisplatin

Gastric Cancer Clinical Trial using cholecystectomy

Italian Research Group for Gastric Cancer - Recruiting 18 years to 80 years.
- The CHOLEGAS Study: Multicentric Randomized, Double-Blinded, Controlled Trial of Gastrectomy Plus Prophylactic Cholecystectomy Versus Gastrectomy Only, in Adults Submitted to Gastric Cancer Surgery With Curative Intent..
cholecystectomy

Stomach Neoplasms Clinical Trial using S-1,oxaliplatin

National Cancer Center, Korea - Recruiting 18 years or older.
- A Randomized Phase II Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma.
S-1,oxaliplatin

Stomach Neoplasms Clinical Trial using S-1,Docetaxel

National Cancer Center, Korea - Recruiting 18 years to 70 years.
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer.
S-1,Docetaxel

Gastric Cancer, Esophageal Cancer, Pancreatic Cancer, or Colon Ca Clinical Trial using S-1

Hamamatsu University - Recruiting 20 years to 85 years.
- Pharmacokinetic and Pharmacodynamic Study of S-1 and Its Effects in Patients With the Digestive Organ Cancer With Reference to Genetic Polymorphism and Activity of CYP2A6 and DPD.
S-1

Gastric Ulcer, Duodenal Ulcer, or Gastric Cancer Clinical Trial using IL-1, TNF-alpha, Il-10

Hamamatsu University - Recruiting N/A or older.
- Effects of Pro-Inflammatory and Anti-Inflammatory Cytokine Gene Polymorphism on the Development of Gastric Cancer and Peptic Ulcer in Japanese.
IL-1, TNF-alpha, Il-10